Cargando…
Use of Praziquantel as an Adjuvant Enhances Protection and Tc-17 Responses to Killed H5N1 Virus Vaccine in Mice
BACKGROUND: H5N1 is a highly pathogenic influenza A virus, which can cause severe illness or even death in humans. Although the widely used killed vaccines are able to provide some protection against infection via neutralizing antibodies, cytotoxic T-lymphocyte responses that are thought to eradicat...
Autores principales: | Zou, Qiang, Hu, Yanxin, Xue, Jia, Fan, Xiaoxu, Jin, Yi, Shi, Xianghua, Meng, Di, Wang, Xianzheng, Feng, Congcong, Xie, Xiaoping, Zhang, Yizhi, Kang, Youmin, Liang, Xiaoxuan, Wu, Bing, Wang, Ming, Wang, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329547/ https://www.ncbi.nlm.nih.gov/pubmed/22529945 http://dx.doi.org/10.1371/journal.pone.0034865 |
Ejemplares similares
-
Praziquantel Facilitates IFN-γ-Producing CD8(+) T Cells (Tc1) and IL-17-Producing CD8(+) T Cells (Tc17) Responses to DNA Vaccination in Mice
por: Zou, Qiang, et al.
Publicado: (2011) -
Anticancer Tc9 cells: Long-lived tumor-killing T cells for adoptive therapy
por: Lu, Yong, et al.
Publicado: (2014) -
Resolution of Praziquantel
por: Woelfle, Michael, et al.
Publicado: (2011) -
The cytotoxicity study of praziquantel enantiomers
por: Sun, Qian, et al.
Publicado: (2016) -
Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial
por: Keiser, Jennifer, et al.
Publicado: (2014)